Skip to main content

Advertisement

Log in

Deforming Polyarthritis in a North Indian Family—Clinical Expansion of STING-Associated Vasculopathy with Onset in Infancy (SAVI)

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Sanchez GAM, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 2014;371(6):507–18.

    Article  CAS  Google Scholar 

  2. Jeremiah N, Neven B, Gentili M, Callebaut I, Maschalidi S, Stolzenberg M-C, et al. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest. 2014;124(12):5516–20.

    Article  Google Scholar 

  3. Tang X, Xu H, Zhou C, Peng Y, Liu H, Liu J, et al. STING-associated vasculopathy with onset in infancy in three children with new clinical aspect and unsatisfactory therapeutic responses to tofacitinib. J Clin Immunol. 2020;40(1):114–22.

    Article  CAS  Google Scholar 

  4. Cao Y, Jiang L-P. The challenge of diagnosing SAVI: case studies. Pediatr Allergy Immunol Pulmonol. 2019;32(4):167–72.

    Article  Google Scholar 

  5. Clarke SLN, Robertson L, Rice GI, Seabra L, Hilliard TN, Crow YJ, et al. Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype. Pediatr Rheumatol Online J. 2020;18(1):37.

    Article  CAS  Google Scholar 

  6. Rodero MP, Tesser A, Bartok E, Rice GI, Della Mina E, Depp M, et al. Type I interferon-mediated autoinflammation due to DNase II deficiency. Nat Commun. 2017;8:2176.

    Article  Google Scholar 

  7. Omoyinmi E, Melo Gomes S, Nanthapisal S, Woo P, Standing A, Eleftheriou D, et al. Stimulator of interferon genes-associated vasculitis of infancy. Arthritis Rheumatol Hoboken NJ. 2015;67(3):808.

    Article  Google Scholar 

  8. Shoman W, El Chazli Y, ElSawy I, Aróstegui JI. First Egyptian patient with STING-associated vasculopathy with onset in infancy. Scand J Rheumatol. 2019;48(4):338–9.

    Article  CAS  Google Scholar 

  9. Seo J, Kang J-A, Suh DI, Park E-B, Lee C-R, Choi SA, et al. Tofacitinib relieves symptoms of stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173. J Allergy Clin Immunol. 2017;139(4):1396–1399.e12.

    Article  CAS  Google Scholar 

  10. Volpi S, Insalaco A, Caorsi R, Santori E, Messia V, Sacco O, et al. Efficacy and adverse events during Janus kinase inhibitor treatment of SAVI syndrome. J Clin Immunol. 2019;39(5):476–85.

    Article  CAS  Google Scholar 

  11. Balci S, Ekinci RMK, de Jesus AA, Goldbach-Mansky R, Yilmaz M. Baricitinib experience on STING-associated vasculopathy with onset in infancy: a representative case from Turkey. Clin Immunol Orlando Fla. 2020;212:108273.

    Article  CAS  Google Scholar 

  12. Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, et al. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest. 2018;128(7):3041–52.

    Article  Google Scholar 

Download references

Acknowledgments

Thanks are due to Shalini N. Jhangiani, Zeynep H. Coban-Akdemir, and Haowei Du from the Baylor College of Medicine Human Genome Sequencing Center and Baylor-Hopkins Center for Mendelian Genomics for the whole exome sequencing and bioinformatics support and Anaid Reyes from the Texas Children’s Hospital Section of Immunology, Allergy, and Retrovirology for the administrative support.

Funding

This work was supported by National Institutes of Health (NIH-NHGRI/NHLBI UM1 HG006542) (to the Baylor-Hopkins Center for Mendelian Genomics).

Author information

Authors and Affiliations

Authors

Contributions

GA, AJ: Patient management, concept of the manuscript, critical review of manuscript for important intellectual content, and final approval of the version to be published

AP: Patient management, concept and draft of manuscript

AK, AR, MS: laboratory support

BY, IC: Genetic analysis by whole exome sequencing

SS: Patient management, important intellectual content, and final approval of the version to be published

Corresponding author

Correspondence to Ankur Kumar Jindal.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Supplementary Figure 1

Clinical photograph of index patient (P1) shows reduced mouth opening (A) and retrognathia (B) (JPG 147 kb)

Supplementary Figure 2

Sanger sequencing showing a heterozygous missense mutation in the exon 5 of STING1 gene (hg19; NM_198282) in the index patient (P1), brother of index patient (P2) and father of index patient (P3) (Chr5:138860432C>T: exon5:c.463G>A:p.V155M) (JPG 147 kb)

Supplementary Table 1

Summary of clinical and laboratory investigations in the index patient and family members (DOCX 23 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anjani, G., Jindal, A.K., Prithvi, A. et al. Deforming Polyarthritis in a North Indian Family—Clinical Expansion of STING-Associated Vasculopathy with Onset in Infancy (SAVI). J Clin Immunol 41, 209–211 (2021). https://doi.org/10.1007/s10875-020-00872-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-020-00872-w

Navigation